Amphastar Pharmaceuticals, Inc. (AMPH)
Company Info
| ISIN | US03209R1032 |
|---|---|
| CUSIP | 03209R103 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
Highlights
| Market Cap | $2.00B |
|---|---|
| EPS (TTM) | $2.91 |
| PE Ratio | 14.07 |
| PEG Ratio | 2.77 |
| Total Revenue (TTM) | $530.50M |
| Gross Profit (TTM) | $289.26M |
| EBITDA (TTM) | $202.42M |
| Year Range | $36.56 - $67.66 |
| Target Price | $63.25 |
| Short % | 12.98% |
| Short Ratio | 12.09 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: AMPH vs. ARCT, AMPH vs. COST, AMPH vs. VOO, AMPH vs. MA, AMPH vs. SPY, AMPH vs. AVGO, AMPH vs. NVO
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Amphastar Pharmaceuticals, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Amphastar Pharmaceuticals, Inc. had a return of -31.87% year-to-date (YTD) and -31.35% in the last 12 months. Over the past 10 years, Amphastar Pharmaceuticals, Inc. had an annualized return of 16.77%, outperforming the S&P 500 benchmark which had an annualized return of 10.58%.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -31.87% | 13.20% |
| 1 month | 3.84% | -1.28% |
| 6 months | -20.85% | 10.32% |
| 1 year | -31.35% | 18.23% |
| 5 years (annualized) | 16.44% | 12.31% |
| 10 years (annualized) | 16.77% | 10.58% |
Monthly Returns
The table below presents the monthly returns of AMPH, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -13.73% | -12.72% | -5.71% | -6.06% | 2.62% | -5.50% | -31.87% | ||||||
| 2023 | 7.99% | 5.29% | 17.70% | -4.61% | 24.04% | 29.52% | 5.60% | -12.16% | -13.73% | -1.57% | 24.41% | 9.82% | 120.74% |
| 2022 | -0.86% | 20.01% | 29.56% | -1.20% | 4.71% | -6.33% | 7.47% | -20.83% | -5.07% | 9.96% | -4.56% | -4.98% | 20.31% |
| 2021 | -9.60% | -3.58% | 4.51% | -5.02% | 8.74% | 6.55% | 3.92% | -6.16% | -3.31% | -1.74% | 4.71% | 19.07% | 15.81% |
| 2020 | -1.97% | -18.61% | -3.57% | 14.22% | 9.97% | 20.49% | -10.86% | 1.80% | -8.00% | 4.48% | -9.34% | 13.23% | 4.25% |
| 2019 | 14.37% | 9.18% | -17.79% | 5.68% | -10.84% | 9.66% | -4.55% | 11.46% | -11.71% | -2.60% | 1.01% | -1.13% | -3.07% |
| 2018 | -3.12% | -1.50% | 2.12% | 1.81% | -17.23% | -3.42% | 14.35% | 8.77% | 1.37% | -6.70% | 21.00% | -8.38% | 3.43% |
| 2017 | -14.50% | -1.78% | -6.27% | 4.14% | 13.05% | 4.63% | -3.25% | -7.35% | 11.62% | 1.12% | 8.41% | -1.79% | 4.45% |
| 2016 | -15.32% | -12.61% | 13.96% | 2.50% | 27.89% | 2.48% | 0.37% | 17.43% | -0.16% | -4.38% | 11.74% | -9.13% | 29.44% |
| 2015 | 4.48% | 15.42% | 6.86% | -3.34% | 6.09% | 14.60% | -7.51% | -20.85% | -9.17% | 1.28% | 29.65% | -7.30% | 22.57% |
| 2014 | 14.40% | -11.29% | 36.15% | -3.64% | -12.96% | 2.86% | 11.31% | 32.69% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of AMPH is 14, indicating that it is in the bottom 14% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Amphastar Pharmaceuticals, Inc. (AMPH) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Amphastar Pharmaceuticals, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Amphastar Pharmaceuticals, Inc. was 49.92%, occurring on Mar 20, 2020. Recovery took 456 trading sessions.
The current Amphastar Pharmaceuticals, Inc. drawdown is 35.17%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -49.92% | Mar 4, 2019 | 266 | Mar 20, 2020 | 456 | Jan 10, 2022 | 722 |
| -43.39% | Nov 18, 2016 | 78 | Mar 14, 2017 | 420 | Nov 9, 2018 | 498 |
| -43.09% | Aug 9, 2023 | 230 | Jul 9, 2024 | — | — | — |
| -42.11% | Jun 26, 2015 | 170 | Feb 29, 2016 | 115 | Aug 11, 2016 | 285 |
| -35.49% | Apr 14, 2022 | 144 | Nov 8, 2022 | 109 | Apr 18, 2023 | 253 |
Volatility
Volatility Chart
The current Amphastar Pharmaceuticals, Inc. volatility is 9.25%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
P/E Ratio
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Amphastar Pharmaceuticals, Inc..
Loading data...
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
| Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
| Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |